» Articles » PMID: 39194921

Dietary Protein and Physical Exercise for the Treatment of Sarcopenia

Overview
Journal Clin Pract
Publisher MDPI
Specialty General Medicine
Date 2024 Aug 28
PMID 39194921
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcopenia is a multifactorial age-related disorder that causes a decrease in muscle mass, strength, and function, leading to alteration of movement, risk of falls, and hospitalization. This article aims to review recent findings on the factors underlying sarcopenia and the strategies required to delay and counteract its symptoms. We focus on molecular factors linked to ageing, on the role of low-grade chronic and acute inflammatory conditions such as cancer, which contributes to the onset of sarcopenia, and on the clinical criteria for its diagnosis. The use of drugs against sarcopenia is still subject to debate, and the suggested approaches to restore muscle health are based on adequate dietary protein intake and physical exercise. We also highlight the difference in the amount and quality of amino acids within animal- and plant-based diets, as studies have often shown varying results regarding their effect on sarcopenia in elderly people. In addition, many studies have reported that non-pharmacological approaches, such as an optimization of dietary protein intake and training programs based on resistance exercise, can be effective in preventing and delaying sarcopenia. These approaches not only improve the maintenance of skeletal muscle function, but also reduce health care costs and improve life expectancy and quality in elderly people.

Citing Articles

Interplay Between Diet, Branched-Chain Amino Acids, and Myokines in Children: Vegetarian Versus Traditional Eating Habits.

Ambroszkiewicz J, Chelchowska M, Mazur J, Rowicka G, Klemarczyk W, Strucinska M Nutrients. 2025; 17(5).

PMID: 40077702 PMC: 11901508. DOI: 10.3390/nu17050834.


A cross-sectional study of risk factors associated with sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease.

Amer J, Abdoh Q, Salous Z, Alsoud E, AbuBaker S, Salhab A Front Med (Lausanne). 2025; 12:1488068.

PMID: 40041458 PMC: 11876153. DOI: 10.3389/fmed.2025.1488068.


Amino Acid and Essential Fatty Acid in Evacuation Shelter Food in the Noto Peninsula Earthquake: Comparison with the 2024 Simultaneous National Survey in Japan.

Sakamoto T, Miyata H, Tsunou A, Hokotachi Y, Sasaki S, Amagai T Nutrients. 2024; 16(23).

PMID: 39683578 PMC: 11643995. DOI: 10.3390/nu16234185.

References
1.
Masucci M, Minopoli M, Di Carluccio G, Motti M, Carriero M . Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer. Cancers (Basel). 2022; 14(3). PMC: 8833673. DOI: 10.3390/cancers14030498. View

2.
Porporato P . Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. 2016; 5:e200. PMC: 5154342. DOI: 10.1038/oncsis.2016.3. View

3.
Roubenoff R, Parise H, Payette H, Abad L, DAgostino R, Jacques P . Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med. 2003; 115(6):429-35. DOI: 10.1016/j.amjmed.2003.05.001. View

4.
Kaji H . Crosstalk between muscle and bone. J Bone Miner Metab. 2023; 42(4):391-398. DOI: 10.1007/s00774-023-01472-5. View

5.
Rolland Y, Dray C, Vellas B, De Souto Barreto P . Current and investigational medications for the treatment of sarcopenia. Metabolism. 2023; 149:155597. DOI: 10.1016/j.metabol.2023.155597. View